SMMT
Summit Therapeutics Inc
Price:  
22.99 
USD
Volume:  
2,983,440.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT Intrinsic Value

-105.21 %
Upside

What is the intrinsic value of SMMT?

As of 2025-07-09, the Intrinsic Value of Summit Therapeutics Inc (SMMT) is -1.20 USD. This SMMT valuation is based on the model Peter Lynch Fair Value. With the current market price of 22.99 USD, the upside of Summit Therapeutics Inc is -105.21%.

Is SMMT undervalued or overvalued?

Based on its market price of 22.99 USD and our intrinsic valuation, Summit Therapeutics Inc (SMMT) is overvalued by 105.21%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

22.99 USD
Stock Price
-1.20 USD
Intrinsic Value
Intrinsic Value Details

SMMT Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -1.20 - -1.20 -1.20 -105.21%
P/E (2.46) - (4.46) (3.21) -114.0%
DDM - Stable (1.56) - (4.63) (3.10) -113.5%
DDM - Multi (0.10) - (0.23) (0.14) -100.6%

SMMT Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 17,073.98
Beta 3.25
Outstanding shares (mil) 742.67
Enterprise Value (mil) 16,862.46
Market risk premium 4.60%
Cost of Equity 11.69%
Cost of Debt 5.00%
WACC 7.68%